Previous Article | Next Article 
Molecular and Cellular Biology, July 2000, p. 4765-4772, Vol. 20, No. 13
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
HuD RNA Recognition Motifs Play Distinct Roles in
the Formation of a Stable Complex with AU-Rich RNA
Sungmin
Park,1
David G.
Myszka,2
Michael
Yu,1
Sarah J.
Littler,1 and
Ite A.
Laird-Offringa1,*
Norris Cancer Center, University of Southern
California, Keck School of Medicine, Los Angeles, California
90089-9176,1 and Huntsman Cancer
Institute, University of Utah, School of Medicine, Salt Lake City,
Utah 841322
Received 24 November 1999/Returned for modification 10 January
2000/Accepted 4 April 2000
 |
ABSTRACT |
Human neuron-specific RNA-binding protein HuD belongs to the family
of Hu proteins and consists of two N-terminal RNA recognition motifs
(RRM1 and -2), a hinge region, and a C-terminal RRM (RRM3). Hu proteins
can bind to AU-rich elements in the 3' untranslated regions of unstable
mRNAs, causing the stabilization of certain transcripts. We have
studied the interaction between HuD and prototype mRNA instability
elements of the sequence UU(AUUU)nAUU using equilibrium methods and real-time kinetics (surface plasmon resonance using a
BIACORE). We show that a single molecule of HuD requires at least three
AUUU repeats to bind tightly to the RNA. Deletion of RRM1 reduced the
Kd by 2 orders of magnitude and caused a
decrease in the association rate and a strong increase in the
dissociation rate of the RNA-protein complex, as expected when a
critical RNA-binding domain is removed. In contrast, deletion of either
RRM2 or -3, which only moderately reduced the affinity, caused marked
increases in the association and dissociation rates. The slower binding and stabilization of the complex observed in the presence of all three
RRMs suggest that a change in the tertiary structure occurs during
binding. The individual RRMs bind poorly to the RNA (RRM1 binds with
micromolar affinity, while the affinities of RRM2 and -3 are in the
millimolar range). However, the combination of RRM1 and either RRM2 or
RRM3 in the context of the protein allows binding with a nanomolar
affinity. Thus, the three RRMs appear to cooperate not only to increase
the affinity of the interaction but also to stabilize the formed
complex. Kinetic effects, similar to those described here, could play a
role in RNA binding by many multi-RRM proteins and may influence the
competition between proteins for RNA-binding sites and the ability of
RNA-bound proteins to be transported intracellularly.
 |
INTRODUCTION |
Hu proteins are a family of highly
conserved RNA-binding proteins that show homology to the
Drosophila protein ELAV (embryonic lethal-altered visual
system) (recently reviewed in references 3 and
43). All ELAV-related proteins contain three RNA
recognition motifs (RRMs; also referred to as RNP domains
[54] or consensus sequence RNA-binding domains
[6]) and have a very similar organization: two closely
spaced N-terminal RRMs, a hinge region of 60 to 90 residues, and a
C-terminal RRM. RRM-containing proteins represent the largest family of
RNA-binding proteins and perform critical functions at all levels of
posttranscriptional gene regulation (54). Four human Hu
proteins, which all have strongly conserved homologues in other
vertebrates, have been identified: HuR, Hel-N1, HuD, and HuC. The
latter three are neuronal proteins (3, 22) and have been
identified as target antigens in paraneoplastic encephalomyelitis-sensory neuronopathy, an autoimmune disease associated with small-cell lung cancer and neuroblastoma (15, 30,
53). Patients with this disease are characterized by high titers
of antibodies against the Hu proteins (which are present in their
tumors) and suffer widespread neuronal destruction (reviewed in
references 16 and 45). The fourth
Hu family member, HuR, is ubiquitously expressed (22, 34).
The neuronal Hu proteins have been proposed to be important regulators
of neuron-specific gene expression that act at the posttranscriptional
level and regulate neuronal growth and differentiation (3,
43). All four proteins can bind tightly to AU-rich sequences
similar to those that cause rapid degradation of unstable mRNAs
(1, 13, 14, 19, 25, 26, 30-32, 34-37, 44, 55). This has
suggested a role for Hu proteins in regulating mRNA stability (see below).
An in vitro selection experiment using Hel-N1 (30) identified an RNA
target consensus sequence similar to the prototype mRNA-destabilizing nonamer independently identified by Zubiaga et al. as UUAUUUAUU (58) and Lagnado et al. as UUAUUUA(U/A)(U/A)
(27). Hel-N1 has since been shown to bind to AU-rich
elements in the 3' untranslated regions (UTRs) of a variety of mRNAs,
such as unstable cytokine and proto-oncogene mRNAs (21, 30),
the glucose transporter mRNA (24, 25), and neurofilament M
mRNA (4). In the latter two cases, the presence of Hel-N1
led to increases in translation and/or stability of the bound mRNAs.
The HuD protein was also found to bind tightly to AU-rich regions of
mRNAs encoding growth-controlling proteins such as c-FOS (14,
32) and the cell cycle regulator p21 (26), as well as
to neuron-specific mRNAs such as N-myc (47),
GAP-43 (encoding a neuron-specific phosphoprotein) (13), and
tau (encoding a microtubule-associated protein) (5). Tau mRNA levels were down regulated by treatment of neuronal cells with
antisense HuD oligonucleotides (5), suggesting that HuD may
be required for a long tau mRNA half-life. The third neuronal Hu
protein, HuC, also binds tightly to AU-rich sequences (1, 48), but a possible role in modulating mRNA stability has not yet
been tested. The final Hu family member, HuR, shows a marked binding
preference for those AU-rich sequences that can function as mRNA
destabilizers (34-37) and can cause stabilization of
vascular endothelial growth factor mRNA and other unstable transcripts in a variety of systems when overexpressed (19, 31, 44). HuR
was recently shown to mediate UV light-induced stabilization of cell
cycle regulator p21 mRNA (55). Thus, the ability to bind to
AU-rich mRNA appears to be a common characteristic of Hu proteins, and
in a number of cases, the formed complexes have been demonstrated to
enhance the stability of labile mRNAs.
While the ability of Hu proteins to bind to AU-rich sequences has been
extensively documented, the molecular interactions allowing specific
binding are still very poorly understood. One reason for this is that
all previous studies used heterogeneous RNA sequences that carried a
variety of possible target sequences, each of which might be bound with
a different affinity. Multiple proteins could be bound to such RNAs,
further complicating the determination of the binding affinity. We
addressed these problems by using a simple RNA target consisting of
UU(AUUU)nAUU repeats, which we used to determine the
minimal binding element. Another reason for the limited understanding
of these interactions is that thus far, the complexes between AU-rich
RNA and Hu proteins have been studied only under equilibrium
conditions. Since the binding of proteins in the cellular environment
is a dynamic process, a clear understanding will be achieved only if
the kinetics of the interactions are also taken into consideration. We
used surface plasmon resonance to measure the kinetics of the
interaction between HuD and AU-rich target RNAs. This powerful
approach, which has only begun to be used to study RNA-protein
interactions and has never been applied to the study of Hu proteins,
can visualize complex formation in real time and can provide unique
insights into the dynamics of association and dissociation
(40). HuD was chosen for our studies because the function of
its RNA-binding domains has been best characterized (14,
35). However, the strong conservation among Hu protein family
members and the neuronal Hu proteins in particular suggests that our
analyses will provide broadly applicable insights into the mechanism by
which this family of proteins binds to AU-rich RNA sequences.
 |
MATERIALS AND METHODS |
Construction of HuD expression plasmids.
The plasmid for the
expression of the full-length recombinant human HuD protein was
generated by high-fidelity PCR using oligonucleotides to engineer an
NcoI-compatible BspHI site at the ATG and an
NotI site immediately following the last codon. The
NcoI site originally present at the ATG was destroyed for
cloning purposes, since the gene contains an internal NcoI
site in the RRM3 region. This resulted in a Glu-to-Ser mutation of the
first residue following the initiator Met. The template used was a
cytomegalovirus-HuD expression vector (provided by G. Manley). It
contained the most common HuD isoform, "HuD," lacking the second
alternative exon in the hinge domain (residues 252 to 265)
(32). RRM1 and RRM1+2 mutants were made by internal deletion
of C-terminal sequences using NotI in combination with the
naturally occurring restriction sites for Ecl136II and MspI, respectively. All other mutants were made by PCR using
high-fidelity polymerase and oligonucleotides designed to engineer
NcoI- and NotI-compatible ends at the 5' and 3'
ends, respectively. The single RRM deletion mutants contain a
SalI site at the position of the deleted RRM. All HuD
fragments were inserted into a derivative of the pET3d vector (Novagen,
Madison, Wis.) encoding a C-terminal hexahistidine and c-myc
epitope tag (28). The composition of the clones is
summarized below (see Fig. 5). Care was taken to choose the boundaries
far enough from the RRMs so as to minimize the risk of disrupting the
RRM tertiary structure.
Purification of HuD and mutants.
HuD full-length protein and
mutants were expressed in Escherichia coli BL21(DE3)
(Novagen) and purified as described for U1A (28), except for
the following modifications. The sonication buffer consisted of 10 mM
Tris-HCl (pH 8.0), 150 mM NaCl, 0.5% Triton X-100, 1 mM
dithiothreitol, and 5 mM imidazole. Proteins were eluted from
Ni2+ beads (Qiagen, Valencia, Calif.) using a sonication
buffer that contained 10% glycerol and increasing concentrations of
imidazole and were eluted mainly at 50 to 150 mM imidazole. Protein
aliquots were stored at
80°C, and thawing and refreezing were
minimized. Protein concentrations were determined by the Bradford
assay, followed by extensive comparisons on Coomassie blue-stained gels to ensure that the relative concentrations of the protein stocks were
very similar (less than 10% different). The identity of the protein
preparations was confirmed by assessing protein size on sodium dodecyl
sulfate-polyacrylamide gel electrophoresis gels for all mutants except
RRM1+2+h and RRM1+h+3, which are very similar in size and were
therefore analyzed by mass spectrometry.
Preparation of RNA targets.
Templates for RNA targets were
generated by annealing the appropriate complementary oligonucleotides
and ligating them into a HindIII-PstI-cleaved
pGEM-derived vector (pEP40) (28). To generate labeled RNA
for gel shift analysis, plasmids were linearized with AccI,
which cuts just downstream of the RNA target, and T7 polymerase-mediated in vitro transcription was performed in the presence of [
-33P]CTP. To generate RNA targets for
BIACORE analysis, unlabeled RNA was in vitro transcribed from templates
linearized with AvaI, resulting in an RNA with a 3'
extension. This allowed annealing to a biotinylated DNA oligonucleotide
for attachment to the BIACORE sensor chip surface. All RNAs were gel
purified before use.
Gel shift analysis.
Gel shifts were performed as described
previously (28) with the following modifications. The
binding buffer consisted of 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.5%
Triton X-100, 0.25 mg of bovine serum albumin per ml, 1 mM
dithiothreitol, 0.5 mg of tRNA per ml, 10% glycerol, and 1 to 2 fmol
of labeled RNA probe. Reactions were equilibrated for 1 h at room
temperature before being loaded on a running Tris-glycine gel (to
minimize complex dissociation) as described previously (28).
(Increasing the incubation time to 2 or 3 h did not substantially
increase the amount of complex.) All gel shifts were done at least
three times. Bands were quantitated using a phosphorimager with
ImageQuant software (Amersham Pharmacia Biotech Inc., Piscataway,
N.J.). Kd values were calculated by plotting the
logarithm of ratio of complexed/free RNA against the logarithm of the
protein concentration, which yields log(Kd) as
the x intercept. Lines were obtained by linear regression.
Surface plasmon resonance (BIACORE) analysis.
BIACORE X and
SA sensor chips were from Biacore Inc. (Piscataway, N.J.). Both flow
cells of an SA streptavidin sensor chip were coated with a low
concentration (about 60 response units) of a biotinylated 20-nucleotide
oligomer complementary to a 19-nucleotide extension present at the 3'
end of the target RNAs (Table 1). The
target RNA was captured on flow cell 2 by manually injecting a 500 nM
solution of the target RNA in 1 M NaCl at a 2-µl/min flow rate. To
minimize mass transport effects, small amounts of RNA were used to coat
the surface (30 to 50 response units). No target RNA was captured on
flow cell 1, so it could be used as a reference surface. The biosensor
assay was run at 25°C in the buffer used for the gel shifts (above).
The proteins (from the same stocks that were used for the gel shifts)
were injected over flow cells 1 and 2 for 2 min at concentrations of
1.2, 3.6, and 11 nM using a flow rate of 30 µl/min. All experiments
included multiple injections of each protein concentration to determine the reproducibility of the signal and control injections to assess the
stability of the RNA surface during the experiment. Bound protein was
removed with a 60-s wash with 2 M NaCl, which did not damage the RNA
surface. Data from flow cell 1 were used to correct for refractive
index changes and nonspecific binding (38). The association
and dissociation phase data were fit simultaneously using the nonlinear
data analysis program CLAMP (41). Binding data were
described by a single-site interaction model including a term for mass
transport of the protein to the sensor surface (39).
 |
RESULTS |
HuD binds to two linked nonamers.
Previous analyses of
HuD-AU-rich-RNA interactions were performed using various fragments of
the c-fos 3' UTR for gel shift analyses and filter-binding
assays (14, 35). The shifted sequences were between 27 and
214 nucleotides long, contained a variety of U-rich and AU-rich
elements, and gave rise to multiple shifted bands, complicating the
interpretation of the data. In order to be able to define the minimal
binding site and the affinity of the interaction, we chose as the RNA
target the previously identified prototype destabilizing nonamer
UUAUUUAUU (27, 58). This nonamer is present in one or more
copies in the 3' UTR of a variety of unstable mRNAs (9, 12,
52), yielding RNA sequences with the pattern
UU(AUUU)nAUU. The repetitive nature of these sequences ensures that the complexity of the number of possible target sequences remains low, thereby simplifying the interpretation of binding data.
Although a single nonamer forms the minimal functional destabilizing
element, two nonamers linked together [resulting in three overlapping
nonamers, or UU(AUUU)3AUU] (Table 1) were shown to be much
more potent destabilizers (27, 58). Therefore, our initial
studies utilized a single nonamer (AU-1), two linked nonamers [UU(AUUU)3AUU, or AU-3], an incomplete nonamer
[(AUUU)2A], and a mutated AU-3 in which the middle U in
each of the triple U sets was replaced by C (MUT). The AU-rich RNAs,
flanked by short constant polylinker sequences derived from the
transcription vector (Table 1), were tested for binding using gel shift
analysis (Fig. 1). HuD bound to AU-3 with
a Kd of 19 ± 3 nM. Although some complex formation was seen with the shorter target RNAs, binding was at least
250-fold weaker, indicating that the AU tracts in those targets are too
short to promote stable complex formation. The weaker binding of the
nonamer was not caused by the absolute length of the RNA, since a
nonamer-containing RNA of the same length as AU-3 (extended with
polylinker sequences) showed the same pattern of binding as the nonamer
(data not shown). The mutation of each central U to C in the MUT target
also greatly diminished binding (Fig. 1D), demonstrating that the
interaction with this target is specific.

View larger version (87K):
[in this window]
[in a new window]
|
FIG. 1.
Analysis of HuD binding to different AU-rich RNA
targets. (A to D) Increasing concentrations of HuD were equilibrated
with different targets and analyzed by gel shift assays. The protein
concentration in nanomolar units is given below each gel. * and P-,
complex and probe (free RNA), respectively. (E) The data from panels A
to D were quantitated and plotted as the percentage of RNA bound versus
the protein concentration.
|
|
In the gel shift of HuD with AU-3, a faint additional band was seen
above the major band at a concentration of 200 nM (Fig. 1C), indicating
that as the RNA is saturated, a small fraction can be bound by a second
protein molecule. This suggested to us that the AU-3 target might be
shortened while still maintaining RNA binding. In order to determine
the minimal binding sequence, we analyzed HuD binding to RNAs
containing shortened AU-rich tracts. The data in Fig. 1 already showed
that a single nonamer sequence is insufficient for optimal binding. Two
sequences of intermediate length [UUAUUUAUUU, or
AU-1+, and UU(AUUU)2AUU, or AU-2], (Table 1)
were tested and found to be bound with an intermediate affinity (Fig.
2), demonstrating that these AU-rich
tracts were still too short to interact optimally. Thus, we conclude
that the minimal target site required for optimal binding of a single
molecule of HuD is 14 to 17 nucleotides long.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Analysis of HuD binding to nonamer repeats of different
lengths. Increasing concentrations of HuD were equilibrated with RNA
targets containing nonamer sequences ranging in length from a single
nonamer to two linked nonamers. Gel shift assays were
quantitated and the data were plotted as in Fig. 1.
|
|
RRM1 is the primary AU-rich-RNA-binding domain.
Previous
studies by Chung and coworkers indicated that RRM1 and -2 are critical
for RNA binding, while RRM3 only marginally affects the
equilibrium-binding affinity (its loss weakens binding approximately
fivefold) (14). However, these experiments were done using a
214-nucleotide AU-rich tract derived from the c-fos 3' UTR.
We used gel shifts to test the ability of HuD mutants lacking each
individual RRM to bind to the AU-3 target (Fig.
3A to C). In accordance with the
previously reported results, we determined that removal of RRM3 causes
only a small (twofold) loss in affinity (Kd is
36 ± 5 nM). Surprisingly, deletion of RRM2 caused a similar minor
reduction in binding affinity (Kd is 36 ± 4 nM), suggesting that this domain is not critical for binding to the
AU-3 target. Only deletion of RRM1 strongly reduced binding and
produced an aberrantly shifted complex that remained in the gel slot.
This was not due to abnormal aggregation of this particular mutant
protein, since normal shifting could be seen when high concentrations
of RRM2+h+3 were added to poly(A) RNA [data not shown; the RRM3
domains of HuD and HuC have been demonstrated to have poly(A) binding
ability (1, 35)]. These results suggested that RRM1 is the
most important RNA-binding domain, while RRM2 and -3 have an accessory
function. However, the RRM2+h+3 clone lacks the N-terminal 35 amino
acids upstream of RRM1 as well as RRM1 itself. Therefore, it could not
be excluded that the removal of these residues, not RRM1 loss, caused
the loss of binding affinity to AU-3. Consequently, we tested RNA
binding of a HuD mutant lacking only the N-terminal 35 residues
(dNterm). This protein binds to RNA as well as the wild-type protein
(Fig. 3G), suggesting that the 35 residues N terminal to RRM1 do not
play a role in AU-rich-RNA binding. A role for the hinge region in RNA
binding was also tested by removing this region from the RRM1+2+h
mutant, generating RRM1+2. The removal of the hinge did not affect
equilibrium binding (Fig. 3G).

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 3.
Analysis of binding of HuD deletion mutants to AU-3 RNA.
(A to F) Increasing concentrations of HuD or deletion mutants were
equilibrated with AU-3 RNA and analyzed by gel shift assays. The
protein concentration is given below each gel. * and P-, complex and
probe (free RNA), respectively. (G) The gel shift data were quantitated
and plotted as in Fig. 1. The graph includes data from RRM1+2 and
dNterm binding reactions (gels not shown) and HuD binding reactions
(Fig. 1) for comparison.
|
|
Shifts using the individual RRMs and AU-3 showed weak but clearly
detectable binding by RRM1 only (Fig. 3D to F), confirming the primary
role of RRM1. The Kd of the RRM1-AU-3 complex
was estimated to be over 100 µM. Shifted bands were also seen with 5 µM RRM2 or RRM3 upon prolonged exposure of the gels. Although the low
amount of signal made it difficult to determine the affinity, we
estimated that the Kd was at least 1 mM. The
weak binding of RRM2 and -3 does not appear to be specific for AU-3
RNA, since at comparable concentrations, these RRMs also bind to RNAs
lacking AUUU sequences (data not shown). Our analysis of the deletion mutants (see Fig. 5) suggests that RRM1 is critical for AU-rich RNA
binding but that at least one additional RRM is required to achieve a
Kd in the nanomolar range.
RRM2 and RRM3 stabilize the RNA-protein complex.
The gel shift
data above show that RRM2 and -3 can be individually deleted without
markedly affecting equilibrium binding to AU-3 RNA. This might suggest
that they play a minor role in RNA binding. However, all three RRMs are
highly conserved. In addition, removal of RRM3 has been shown to
profoundly affect the biological activity of members of the Hu protein
family (2, 19). We reasoned that loss of RRM2 or -3 might
affect the kinetics of complex formation. To address this question, we
analyzed the interaction of HuD and mutants lacking the individual RRMs
with AU-3 by surface plasmon resonance using a BIACORE X. The
sensorgrams for HuD, injected over an AU-3 RNA surface, are shown in
Fig. 4A. A single-site interaction model,
including a term for mass transport, provided an excellent fit to the
binding data, yielding an association rate (ka)
of 4.21 × 106 M
1 s
1, a
dissociation rate (kd) of 3.05 × 10
3 s
1, and a resulting
Kd of 0.7 nM (Table
2). The fact that this value is lower
than that obtained by gel shift analysis is probably due to technical
differences. While association and dissociation are observed in real
time when the BIACORE is used, equilibrium measurements obtained by gel
shifts rely on the maintenance of the intact complex. However, the
complex might (partially) dissociate during gel loading or running, in
which case the affinity would be underestimated (see Discussion).
Interestingly, analysis of the interaction between AU-3 and the mutant
lacking RRM3 showed a pronounced change in the kinetics of complex
formation to higher association and dissociation rates (Fig. 4B; Table
2). Additional removal of the hinge region from the RRM1+2+h mutant led
to a further change in the kinetics of binding (Fig. 4C; Table 2). While the HuD complex dissociates relatively slowly with an estimated half-life of approximately 4 min, the half-life of the RRM1+2+h complex
is less than 16 s and that of the RRM1+2 complex is less than
4 s. Deletion of RRM2 causes kinetic changes comparable to those
caused by deletion of RRM3 (Fig. 4D; Table 2), suggesting that RRM2 and
-3 play similar roles in binding. The increased dissociation rate of
these mutants can be explained by possible contacts of RRM2 and -3 with
the RNA, which are lost upon removal of the RRMs. However, this
enhanced dissociation rate is accompanied by an increased association
rate, suggesting that the mutants can bind more easily to the RNA. The
likeliest explanation for this observation is that a change in tertiary
structure may accompany binding of HuD to AU-3 and that the mutant
proteins are less restricted and can therefore bind more readily to the
RNA. In contrast, deletion of RRM1 causes
a decrease in the association rate and a strong increase in the
dissociation rate, as would be expected when a domain critical for
binding is removed. We conclude that RRM2 and -3 are functionally
distinct from RRM1 and that the hinge region and RRM2 and -3 play a
role in stabilizing the RNA-protein complex, possibly by mediating a
change in tertiary structure. Our analyses emphasize the importance of
taking binding kinetics into account, since the remarkable kinetic
effects of the mutants would have gone undetected by relying on
equilibrium analysis alone.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 4.
Kinetic analysis of HuD-RNA interactions. The binding of
wild-type HuD and RRM mutants to an AU-3 RNA target surface is shown.
Black lines represent the binding responses for three replicate
injections of each protein at 1.2, 3.6, and 11 nM over the RNA surface.
In order to detect the much weaker binding of RRM2+h+3, the
concentrations represented in panel E were 3.6, 11, and 33 nM, and
threefold more RNA was used for coating. Protein was injected at time
zero and exposed to the surface for 120 s (association phase),
followed by a 3-min flow of running buffer during which dissociation
could be observed. Red lines represent a global fit of each data set to
a single-site interaction model including mass transport. The resulting
parameter values are given in Table 2.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 5.
Comparison of equilibrium binding affinities of HuD and
deletion mutants for AU-3 RNA. Names of clones and residues present are
given at left. Kd values as determined by gel
shift analyses are given at right. No error margin was given for the
RRM1, RRM2, and RRM3 values, since binding was too weak to allow an
accurate estimation of the Kd. *, value based
on quantitation of RNA trapped in the slot. Since it is unclear whether
this represents true RNA-bound complex, the actual affinity may be much
weaker.
|
|
 |
DISCUSSION |
Our results demonstrate that HuD binds tightly and specifically to
the sequence UU(AUUU)3AUU, which is known to be a very potent mRNA instability element. This motif and variations thereof are
found in ubiquitous mRNAs such as cytokine mRNAs, immediate early
proto-oncogene mRNAs, and cell cycle-regulatory mRNAs (9). They are also found in transcripts relevant to neuronal signaling and/or differentiation, such as c-fos and other immediate
early genes that are induced upon neuronal stimulation (reviewed in reference 20) and neuritin mRNA, which encodes a
protein that promotes neuritogenesis and which contains a perfect AU-3
sequence in its 3' UTR (42). AU-rich instability elements
are thought to mediate two steps in mRNA decay: the loss of the poly(A)
tail, which is the first and rate-limiting step in this decay pathway, and the subsequent destruction of the mRNA body (reviewed in references 12 and 46). Proteins that bind to
these sequences have the potential to promote or prevent mRNA decay.
Recent studies involving the overexpression of Hu proteins suggest that
increased expression of these proteins is associated with mRNA
stabilization and could be involved in proto-oncogene deregulation in
cancer (10, 11, 19, 31, 44, 55). In contrast, overexpression
of AUF1 (also known as hnRNP D), an AU-rich binding protein isolated
through work with an in vitro mRNA decay system (57),
appears to promote decay (29, 33). It has been suggested
that Hu proteins might compete with AUF1 for binding to AU-rich
sequences and that the identity of the bound protein might determine
the fate of the mRNA. If such a competition for binding actually takes
place inside the cell, issues of affinity and kinetics are of prime
importance. For example, replacement of an Hu protein on mRNA by AUF1
would require that the Hu protein dissociate from the RNA and would depend on the relative concentrations of the two proteins and their
respective affinities. For this reason, it is essential to study not
only the equilibrium binding affinities of Hu-RNA complexes but also
the kinetics of complex formation. This will increase our understanding
of how Hu proteins might compete with other AU-rich-RNA-binding
proteins and will be crucial for dissecting the exact mechanism of RNA
recognition and binding.
A previous study, which identified HuD RRM1 and RRM2 as critical for
binding to AU-rich sequences derived from the c-fos mRNA 3'
UTR, reported that RRM2 alone could bind as well as RRM1 to the
c-fos 3' UTR (14). However, our data (summarized
in Fig. 5) show that RRM2 binds much more weakly than RRM1, suggesting that the role of RRM2 is secondary to that of RRM1. This conclusion is
supported by binding experiments with HuD mutants lacking RRM1 or RRM2.
Deletion of RRM2 only marginally reduces the affinity for the AU-3
target, while deletion of RRM1 causes a profound change in the shifted
pattern and a strong loss in affinity.
Two reasons could explain why our results do not agree with previously
published HuD data. First, the borders of the RRM2 fragments used for
the studies are not identical. Our RRM2 fragment is eight amino acids
shorter at the N-terminal end than the RRM2 fragment in the previous
study. However, our RRM2 fragment does include the full RRM motif and
does show weak binding to AU-3 RNA at high concentrations. Secondly,
the RNA targets are different, since we used small, well-defined
repeats of the nonamer sequence, while the other investigators used a
214-nucleotide fragment from the c-fos 3' UTR. The
c-fos fragment contains a variety of sequences and might
allow RRM2 binding through interactions with parts of the mRNA outside
the AU-rich element. It is noteworthy that our results closely resemble
those obtained in a study of HuC binding to a 27-nucleotide in
vitro-selected AU-rich RNA (1). In this HuC study, RRM1 was
determined to be the major RNA-binding determinant, but strong binding
was seen only when RRM2 was added. A mutant lacking RRM2 but containing
RRM3 (our RRM1+h+3) was not tested in previous HuD or HuC studies. The
RNA-binding ability of Hel-N1 has also been studied by deletion
analysis (30). The RNA target used was a large fragment of
the c-myc 3' UTR, which was not bound by Hel-N1 fragments
consisting of RRM1 alone or RRM1 and part of RRM2 (an RRM1+2 clone was
not tested) but only by a fragment consisting of RRM3. This led some
investigators to conclude that RRM3 encodes AU-rich-RNA-binding
activity. However, the strong conservation among the three neuronal Hu
proteins suggests that this is unlikely. Binding of RRM3 to sequences
other than AU-rich elements (such as an A-rich tract) could have
resulted in binding of Hel-N1 RRM3 to the c-myc UTR, and the
AU-rich affinity of the two N-terminal RRMs may have been missed
because the clone was not complete. It would be useful to test the
RNA-binding specificity of a Hel-N1 RRM1+2 clone to resolve this issue.
It is of interest that binding of HuD to AU-3 with a nanomolar affinity
is achieved only in the presence of RRM1 with at least one additional
RRM. A similar phenomenon is observed with many multi-RRM proteins. For
example, in Sx1 (49), hnRNP A1 (51), poly(A)-binding protein (7), nucleolin (50), SF2
(also known as ASF) (8), and U2AF (56), binding
by a single RRM is much weaker and/or less specific than binding by a
combination of two or more RRMs. Of the multiple RRMs these proteins
contain, one is often found to confer the predominant RNA-binding
activity and/or specificity (e.g., RRM2 in hnRNP A1
[51], RRM2 in poly(A)-binding protein
[17], RRM1 in nucleolin [50]). Thus,
our HuD results fit the idea that tight and specific binding is usually
not achieved with a single RRM domain. What is new about our
observations is that the different RRMs appear not only to play a role
in increasing specificity and affinity but also to be able to change
the kinetics of complex formation. Perhaps stabilization by the third
RRM occurs by locking the RNA-bound complex in a stable
three-dimensional structure. Achieving this structure would slow
association, but once achieved, the structure would be quite stable.
This is exactly what we observe when comparing the kinetics of the
full-length protein with those of mutants lacking RRM2 or RRM3. Our
results indicate that all three RRMs are required and that in contrast to previous suggestions (14), RRM3 is not dispensable for binding.
The importance of RRM3 is shown by experiments demonstrating that HuR
lacking the C-terminal RRM cannot stabilize RNA when transfected into
tissue culture cells (19) and that the RRM3 fragment of HuC
or Hel-N1 can act in a dominant negative fashion to prevent Hu
protein-induced differentiation of PC12 cells (2). A
possible regulatory function of RRM3 might be linked to its ability to
bind to long poly(A) tracts (1, 35). If the presence of Hu
proteins is correlated with increased mRNA stability, one would expect
these proteins to be bound to newly made mRNAs with long poly(A) tails.
Such binding could be enhanced by RRM3, whose bond with the poly(A)
tail could stabilize the interaction of the two N-terminal RRMs with
the AU-rich tract. Loss of the poly(A) tail (the first step in decay)
might then be followed by release of the Hu protein, allowing a
destabilizer protein (e.g., AUF1) to bind and mediate the next decay
step. These ideas suggest that studying the effect of poly(A) tracts on
the kinetics of AU-rich-RNA binding is highly relevant. Such studies
are in progress.
Our observation that the effect of certain deletions on binding is not
detected using equilibrium binding analyses such as gel shift assays
reinforces the concept that the study of RNA-protein interactions must
be expanded to include analyses of the kinetics of complex formation. A
further caveat of gel shift assays is that they depend on the detection
of complexes formed in equilibrated binding assays. Even though the
"caging effect" is thought to prevent complexes from dissociating
after they have entered the gel, complexes could dissociate during
loading (although samples were loaded on a running gel to minimize this
possibility). Because of this, complexes that associate slowly and/or
dissociate quickly may not be fully detected. In contrast, binding in
the BIACORE is recorded in real time, allowing the process of complex
formation to be visualized. We note that, in spite of these
differences, the rankings of the affinities of the full-length protein
and deletion mutants obtained by gel shift analysis and the BIACORE are consistent.
The studies of the interaction between HuD and AU-rich mRNA described
here form a solid basis for establishing a deep understanding of the
dynamic process of RNA recognition by Hu proteins, as well as by
multi-RRM proteins in general. As mentioned above, RNA-binding proteins
containing multiple RRMs abound (54). While the role of the
different RRMs has been studied for several of these proteins using
equilibrium analyses and the cocrystal structure of the RNA-multi-RRM
protein complex has been elucidated in two cases (18, 23),
the mechanisms of complex formation remain largely unknown. Kinetic
studies like those described here will be critical for understanding
how the dynamics of the interaction and the interplay between the
different RRMs allow these proteins to recognize and trap their RNA
targets. Kinetic effects could play a role in RNA binding by many
multi-RRM proteins and may influence the competition between proteins
for RNA-binding sites and the ability of RNA-bound proteins to be
transported intracellularly.
 |
ACKNOWLEDGMENTS |
We thank Geoffrey Manley and Henry Furneaux for providing HuD
cDNA clones, Shirley Demer of BIACORE, Inc. for help with our initial
BIACORE assays, Debbie Johnson and Michael Lieber for critical comments
on the manuscript, and the members of the Laird-Offringa lab for
helpful and enthusiastic discussions.
This work was supported by American Cancer Society Institutional
Research Grant IRG-21-37, grants from the American Lung Association, National Institutes of Health grant R29CA78407, a CHLA/USC Summer Oncology Fellowship (to M.Y.), and a generous gift from Mary Lou and
Eri Mettler.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: USC/Norris
Cancer Center, Room NOR 6420, 1441 Eastlake Ave., Los Angeles, CA
90089-9176. Phone: (323) 865-0655. Fax: (323) 865-0158. E-mail:
ilaird{at}hsc.usc.edu.
 |
REFERENCES |
| 1.
|
Abe, R.,
E. Sakashita,
K. Yamamoto, and H. Sakamoto.
1996.
Two different RNA binding activities for the AU-rich element and the poly(A) sequence of the mouse neuronal protein mHuC.
Nucleic Acids Res.
24:4895-4901[Abstract/Free Full Text].
|
| 2.
|
Akamatsu, W.,
H. J. Okano,
N. Osumi,
T. Inoue,
S. Nakamura,
S. Sakakibara,
M. Miura,
N. Matsuo,
R. B. Darnell, and H. Okano.
1999.
Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems.
Proc. Natl. Acad. Sci. USA
96:9885-9890[Abstract/Free Full Text].
|
| 3.
|
Antic, D., and J. D. Keene.
1997.
Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression.
Am. J. Hum. Genet.
61:273-278[Medline].
|
| 4.
|
Antic, D.,
N. Lu, and J. D. Keene.
1999.
ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells.
Genes Dev.
13:449-461[Abstract/Free Full Text].
|
| 5.
|
Aranda-Abreu, G. E.,
L. Behar,
S. Chung,
H. Furneaux, and I. Ginzburg.
1999.
Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cells.
J. Neurosci.
19:6907-6917[Abstract/Free Full Text].
|
| 6.
|
Burd, C. G., and G. Dreyfuss.
1994.
Conserved structures and diversity of functions of RNA-binding proteins.
Science
265:615-621[Abstract/Free Full Text].
|
| 7.
|
Burd, C. G.,
E. L. Matunis, and G. Dreyfuss.
1991.
The multiple RNA-binding domains of the mRNA poly(A)-binding protein have different RNA-binding activities.
Mol. Cell. Biol.
11:3419-3424[Abstract/Free Full Text].
|
| 8.
|
Caceres, J. F., and A. R. Krainer.
1993.
Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains.
EMBO J.
12:4715-4726[Medline].
|
| 9.
|
Caput, D.,
B. Beutler,
K. Hartog,
R. Thayer,
S. Brown-Shimer, and A. Cerami.
1986.
Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.
Proc. Natl. Acad. Sci. USA
83:1670-1674[Abstract/Free Full Text].
|
| 10.
|
Chagnovich, D., and S. L. Cohn.
1996.
Binding of a 40-kDa protein to the N-myc 3'-untranslated region correlates with enhanced N-myc expression in human neuroblastoma.
J. Biol. Chem.
271:33580-33586[Abstract/Free Full Text].
|
| 11.
|
Chagnovich, D., and S. L. Cohn.
1997.
Activity of a 40 kDa RNA-binding protein correlates with MYCN and c-fos mRNA stability in human neuroblastoma.
Eur. J. Cancer
33:2064-2067.
|
| 12.
|
Chen, C. Y., and A. B. Shyu.
1995.
AU-rich elements: characterization and importance in mRNA degradation.
Trends Biochem. Sci.
20:465-470[CrossRef][Medline].
|
| 13.
|
Chung, S.,
M. Eckrich,
N. Perrone-Bizzozero,
D. T. Kohn, and H. Furneaux.
1997.
The Elav-like proteins bind to a conserved regulatory element in the 3'-untranslated region of GAP-43 mRNA.
J. Biol. Chem.
272:6593-6598[Abstract/Free Full Text].
|
| 14.
|
Chung, S.,
L. Jiang,
S. Cheng, and H. Furneaux.
1996.
Purification and properties of HuD, a neuronal RNA-binding protein.
J. Biol. Chem.
271:11518-11524[Abstract/Free Full Text].
|
| 15.
|
Dalmau, J.,
H. M. Furneaux,
C. Cordon-Cardo, and J. Posner.
1992.
The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues.
Am. J. Pathol.
141:881-886[Abstract].
|
| 16.
|
Darnell, R. B.
1996.
Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity and the brain.
Proc. Natl. Acad. Sci. USA
93:4529-4536[Abstract/Free Full Text].
|
| 17.
|
Deardorff, J. A., and A. B. Sachs.
1997.
Differential effects of aromatic and charged residue substitutions in the RNA binding domains of the yeast poly(A)-binding protein.
J. Mol. Biol.
269:67-81[CrossRef][Medline].
|
| 18.
|
Deo, R. C.,
J. B. Bonanno,
N. Sonenberg, and S. K. Burley.
1999.
Recognition of polyadenylate RNA by the poly(A)-binding protein.
Cell
98:835-845[CrossRef][Medline].
|
| 19.
|
Fan, X. C., and J. A. Steitz.
1998.
Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs.
EMBO J.
17:3448-3460[CrossRef][Medline].
|
| 20.
|
Finkbeiner, S., and M. E. Greenberg.
1998.
Ca2+ channel-regulated neuronal gene expression.
J. Neurobiol.
37:171-189[CrossRef][Medline].
|
| 21.
|
Gao, F. B.,
C. C. Carson,
T. Levine, and J. D. Keene.
1994.
Selection of a subset of mRNAs from combinatorial 3' untranslated region libraries using neuronal RNA-binding protein Hel-N1.
Proc. Natl. Acad. Sci. USA
91:11207-11211[Abstract/Free Full Text].
|
| 22.
|
Good, P. J.
1995.
A conserved family of elav-like genes in vertebrates.
Proc. Natl. Acad. Sci. USA
92:4557-4561[Abstract/Free Full Text].
|
| 23.
|
Handa, N.,
O. Nureki,
K. Kurimoto,
I. Kim,
H. Sakamoto,
Y. Shimura,
Y. Muto, and S. Yokoyama.
1999.
Structural basis for recognition of the tra mRNA precursor by the Sex-lethal protein.
Nature
398:579-585[CrossRef][Medline].
|
| 24.
|
Jain, R. G.,
L. G. Andrews,
K. M. McGowan,
F. Gao,
J. D. Keene, and P. P. Pekala.
1995.
Hel-N1, an RNA-binding protein, is a ligand for an A + U rich region of the GLUT1 3' UTR.
Nucleic Acids Symp. Ser.
33:209-211.
|
| 25.
|
Jain, R. G.,
L. G. Andrews,
K. M. McGowan,
P. H. Pekala, and J. D. Keene.
1997.
Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes.
Mol. Cell. Biol.
17:954-962[Abstract].
|
| 26.
|
Joseph, B.,
M. Orlian, and H. Furneaux.
1998.
p21(waf1) mRNA contains a conserved element in its 3'-untranslated region that is bound by the Elav-like mRNA-stabilizing proteins.
J. Biol. Chem.
273:20511-20516[Abstract/Free Full Text].
|
| 27.
|
Lagnado, C. A.,
C. Y. Brown, and G. J. Goodall.
1994.
AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A).
Mol. Cell. Biol.
14:7984-7995[Abstract/Free Full Text].
|
| 28.
|
Laird-Offringa, I. A., and J. G. Belasco.
1995.
Analysis of RNA-binding proteins by in vitro genetic selection: identification of an amino acid residue important for locking U1A onto its RNA target.
Proc. Natl. Acad. Sci. USA
92:11859-11863[Abstract/Free Full Text].
|
| 29.
|
Laroia, G.,
R. Cuesta,
G. Brewer, and R. J. Schneider.
1999.
Control of mRNA decay by heat shock-ubiquitin-proteasome pathway.
Science
284:499-502[Abstract/Free Full Text].
|
| 30.
|
Levine, T. D.,
F. Gao,
P. H. King,
L. G. Andrews, and J. D. Keene.
1993.
Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs.
Mol. Cell. Biol.
13:3494-3504[Abstract/Free Full Text].
|
| 31.
|
Levy, N. S.,
S. Chung,
H. Furneaux, and A. P. Levy.
1998.
Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR.
J. Biol. Chem.
273:6417-6423[Abstract/Free Full Text].
|
| 32.
|
Liu, J.,
J. Dalmau,
A. Szabo,
M. Rosenfeld,
J. Huber, and H. Furneaux.
1995.
Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA.
Neurology
45:544-550[Abstract/Free Full Text].
|
| 33.
|
Loflin, P.,
C. Y. Chen, and A. B. Shyu.
1999.
Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element.
Genes Dev.
13:1884-1897[Abstract/Free Full Text].
|
| 34.
|
Ma, W. J.,
S. Cheng,
C. Campbell,
A. Wright, and H. Furneaux.
1996.
Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein.
J. Biol. Chem.
271:8144-8151[Abstract/Free Full Text].
|
| 35.
|
Ma, W. J.,
S. Chung, and H. Furneaux.
1997.
The Elav-like proteins bind to AU-rich elements and to the poly(A) tail of mRNA.
Nucleic Acids Res.
25:3564-3569[Abstract/Free Full Text].
|
| 36.
|
Maurer, F.,
M. Tierney, and R. L. Medcalf.
1999.
An AU-rich sequence in the 3'-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR.
Nucleic Acids Res.
27:1664-1673[Abstract/Free Full Text].
|
| 37.
|
Myer, V. E.,
X. C. Fan, and J. A. Steitz.
1997.
Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay.
EMBO J.
16:2130-2139[CrossRef][Medline].
|
| 38.
|
Myszka, D. G.
1999.
Improving biosensor analysis.
J. Mol. Recognit.
12:279-284[CrossRef][Medline].
|
| 39.
|
Myszka, D. G.,
X. He,
M. Dembo,
T. A. Morton, and B. Goldstein.
1998.
Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data.
Biophys. J.
75:583-594[Abstract/Free Full Text].
|
| 40.
|
Myszka, D. G.,
M. D. Jonsen, and B. J. Graves.
1998.
Equilibrium analysis of high affinity interactions using BIACORE.
Anal. Biochem.
265:326-330[CrossRef][Medline].
|
| 41.
|
Myszka, D. G., and T. A. Morton.
1998.
CLAMP: a biosensor kinetic data analysis program.
Trends Biochem. Sci.
23:149-150[CrossRef][Medline].
|
| 42.
|
Naeve, G. S.,
M. Ramakrishnan,
R. Kramer,
D. Hevroni,
Y. Citri, and L. E. Theill.
1997.
Neuritin: a gene induced by neural activity and neurotrophins that promotes neuritogenesis.
Proc. Natl. Acad. Sci. USA
94:2648-2653[Abstract/Free Full Text].
|
| 43.
|
Okano, H. J., and R. B. Darnell.
1997.
A hierarchy of Hu RNA binding proteins in developing and adult neurons.
J. Neurosci.
17:3024-3037[Abstract/Free Full Text].
|
| 44.
|
Peng, S. S.,
C. Y. Chen,
N. Xu, and A. B. Shyu.
1998.
RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein.
EMBO J.
17:3461-3470[CrossRef][Medline].
|
| 45.
|
Posner, J. B.
1994.
The anti-Hu syndrome: a model paraneoplastic disorder.
Recent Results Cancer Res.
135:77-90[Medline].
|
| 46.
|
Ross, J.
1995.
mRNA stability in mammalian cells.
Microbiol. Rev.
59:423-450[Abstract/Free Full Text].
|
| 47.
|
Ross, R. A.,
D. L. Lazarova,
G. T. Manley,
P. S. Smitt,
B. A. Spengler,
J. B. Posner, and J. L. Biedler.
1997.
HuD, a neuronal-specific RNA-binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells.
Eur. J. Cancer
33:2071-2074.
|
| 48.
|
Sakai, K.,
Y. Kitagawa, and G. Hirose.
1999.
Analysis of the RNA recognition motifs of human neuronal ELAV-like proteins in binding to a cytokine mRNA.
Biochem. Biophys. Res. Commun.
256:263-268[CrossRef][Medline].
|
| 49.
|
Samuels, M.,
G. Deshpande, and P. Schedl.
1998.
Activities of the Sex-lethal protein in RNA binding and protein:protein interactions.
Nucleic Acids Res.
26:2625-2637[Abstract/Free Full Text].
|
| 50.
|
Serin, G.,
G. Joseph,
L. Ghisolfi,
M. Bauzan,
M. Erard,
F. Amalric, and P. Bouvet.
1997.
Two RNA-binding domains determine the RNA-binding specificity of nucleolin.
J. Biol. Chem.
272:13109-13116[Abstract/Free Full Text].
|
| 51.
|
Shamoo, Y.,
N. Abdul-Manan,
A. M. Patten,
J. K. Crawford,
M. C. Pellegrini, and K. R. Williams.
1994.
Both RNA-binding domains in heterogeneous nuclear ribonucleoprotein A1 contribute toward single-stranded-RNA binding.
Biochemistry
33:8272-8282[CrossRef][Medline].
|
| 52.
|
Shaw, G., and R. Kamen.
1986.
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.
Cell
46:659-667[CrossRef][Medline].
|
| 53.
|
Szabo, A.,
J. Dalmau,
G. Manley,
M. Rosenfeld,
E. Wong,
J. Henson,
J. B. Posner, and H. M. Furneaux.
1991.
HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal.
Cell
67:325-333[CrossRef][Medline].
|
| 54.
|
Varani, G., and K. Nagai.
1998.
RNA recognition by RNP proteins during RNA processing.
Annu. Rev. Biophys. Biomol. Struct.
27:407-445[CrossRef][Medline].
|
| 55.
|
Wang, W.,
H. Furneaux,
H. Cheng,
M. C. Caldwell,
D. Hutter,
Y. Liu,
N. Holbrook, and M. Gorospe.
2000.
HuR regulates p21 mRNA stabilization by UV light.
Mol. Cell. Biol.
20:760-769[Abstract/Free Full Text].
|
| 56.
|
Zamore, P. D.,
J. G. Patton, and M. R. Green.
1992.
Cloning and domain structure of the mammalian splicing factor U2AF.
Nature
355:609-614[CrossRef][Medline].
|
| 57.
|
Zhang, W.,
B. J. Wagner,
K. Ehrenman,
A. W. Schaefer,
C. T. DeMaria,
D. Crater,
K. DeHaven,
L. Long, and G. Brewer.
1993.
Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1.
Mol. Cell. Biol.
13:7652-7665[Abstract/Free Full Text].
|
| 58.
|
Zubiaga, A. M.,
J. G. Belasco, and M. E. Greenberg.
1995.
The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation.
Mol. Cell. Biol.
15:2219-2230[Abstract].
|
Molecular and Cellular Biology, July 2000, p. 4765-4772, Vol. 20, No. 13
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Moulton, V. R., Kyttaris, V. C., Juang, Y.-T., Chowdhury, B., Tsokos, G. C.
(2008). The RNA-stabilizing Protein HuR Regulates the Expression of {zeta} Chain of the Human T Cell Receptor-associated CD3 Complex. J. Biol. Chem.
283: 20037-20044
[Abstract]
[Full Text]
-
Hartmann, C., Benz, C., Brems, S., Ellis, L., Luu, V.-D., Stewart, M., D'Orso, I., Busold, C., Fellenberg, K., Frasch, A. C. C., Carrington, M., Hoheisel, J., Clayton, C. E.
(2007). Small Trypanosome RNA-Binding Proteins TbUBP1 and TbUBP2 Influence Expression of F-Box Protein mRNAs in Bloodstream Trypanosomes. Eukaryot Cell
6: 1964-1978
[Abstract]
[Full Text]
-
Kim, H. S., Kuwano, Y., Zhan, M., Pullmann, R. Jr., Mazan-Mamczarz, K., Li, H., Kedersha, N., Anderson, P., Wilce, M. C. J., Gorospe, M., Wilce, J. A.
(2007). Elucidation of a C-Rich Signature Motif in Target mRNAs of RNA-Binding Protein TIAR. Mol. Cell. Biol.
27: 6806-6817
[Abstract]
[Full Text]
-
Fialcowitz-White, E. J., Brewer, B. Y., Ballin, J. D., Willis, C. D., Toth, E. A., Wilson, G. M.
(2007). Specific Protein Domains Mediate Cooperative Assembly of HuR Oligomers on AU-rich mRNA-destabilizing Sequences. J. Biol. Chem.
282: 20948-20959
[Abstract]
[Full Text]
-
Law, M. J., Rice, A. J., Lin, P., Laird-Offringa, I. A.
(2006). The role of RNA structure in the interaction of U1A protein with U1 hairpin II RNA. RNA
12: 1168-1178
[Abstract]
[Full Text]
-
Prechtel, A. T., Chemnitz, J., Schirmer, S., Ehlers, C., Langbein-Detsch, I., Stulke, J., Dabauvalle, M.-C., Kehlenbach, R. H., Hauber, J.
(2006). Expression of CD83 Is Regulated by HuR via a Novel cis-Active Coding Region RNA Element. J. Biol. Chem.
281: 10912-10925
[Abstract]
[Full Text]
-
Fujiwara, T., Mori, Y., Chu, D. L., Koyama, Y., Miyata, S., Tanaka, H., Yachi, K., Kubo, T., Yoshikawa, H., Tohyama, M.
(2006). CARM1 Regulates Proliferation of PC12 Cells by Methylating HuD.. Mol. Cell. Biol.
26: 2273-2285
[Abstract]
[Full Text]
-
Borgeson, C. D., Samson, M.-L.
(2005). Shared RNA-binding sites for interacting members of the Drosophila ELAV family of neuronal proteins. Nucleic Acids Res
33: 6372-6383
[Abstract]
[Full Text]
-
Law, M. J., Chambers, E. J., Katsamba, P. S., Haworth, I. S., Laird-Offringa, I. A.
(2005). Kinetic analysis of the role of the tyrosine 13, phenylalanine 56 and glutamine 54 network in the U1A/U1 hairpin II interaction. Nucleic Acids Res
33: 2917-2928
[Abstract]
[Full Text]
-
Chen, H., Gill, A., Dove, B. K., Emmett, S. R., Kemp, C. F., Ritchie, M. A., Dee, M., Hiscox, J. A.
(2005). Mass Spectroscopic Characterization of the Coronavirus Infectious Bronchitis Virus Nucleoprotein and Elucidation of the Role of Phosphorylation in RNA Binding by Using Surface Plasmon Resonance. J. Virol.
79: 1164-1179
[Abstract]
[Full Text]
-
Buu, L.-M., Jang, L.-T., Lee, F.-J. S.
(2004). The Yeast RNA-binding Protein Rbp1p Modifies the Stability of Mitochondrial Porin mRNA. J. Biol. Chem.
279: 453-462
[Abstract]
[Full Text]
-
Park-Lee, S., Kim, S., Laird-Offringa, I. A.
(2003). Characterization of the Interaction between Neuronal RNA-binding Protein HuD and AU-rich RNA. J. Biol. Chem.
278: 39801-39808
[Abstract]
[Full Text]
-
D'Orso, I., Frasch, A. C. C.
(2002). TcUBP-1, an mRNA Destabilizing Factor from Trypanosomes, Homodimerizes and Interacts with Novel AU-rich Element- and Poly(A)-binding Proteins Forming a Ribonucleoprotein Complex. J. Biol. Chem.
277: 50520-50528
[Abstract]
[Full Text]
-
Li, H., Park, S., Kilburn, B., Jelinek, M. A., Henschen-Edman, A., Aswad, D. W., Stallcup, M. R., Laird-Offringa, I. A.
(2002). Lipopolysaccharide-induced Methylation of HuR, an mRNA-stabilizing Protein, by CARM1. J. Biol. Chem.
277: 44623-44630
[Abstract]
[Full Text]
-
Bonnet-Corven, S., Audic, Y., Omilli, F., Osborne, H. B.
(2002). An analysis of the sequence requirements of EDEN-BP for specific RNA binding. Nucleic Acids Res
30: 4667-4674
[Abstract]
[Full Text]
-
Chen, C.-Y. A., Xu, N., Shyu, A.-B.
(2002). Highly Selective Actions of HuR in Antagonizing AU-Rich Element-Mediated mRNA Destabilization. Mol. Cell. Biol.
22: 7268-7278
[Abstract]
[Full Text]
-
Katsamba, P. S., Bayramyan, M., Haworth, I. S., Myszka, D. G., Laird-Offringa, I. A.
(2002). Complex role of the beta 2-beta 3 Loop in the Interaction of U1A with U1 Hairpin II RNA. J. Biol. Chem.
277: 33267-33274
[Abstract]
[Full Text]
-
Toba, G., Qui, J., Koushika, S. P., White, K.
(2002). Ectopic expression of Drosophila ELAV and human HuD in Drosophila wing disc cells reveals functional distinctions and similarities. J. Cell Sci.
115: 2413-2421
[Abstract]
[Full Text]
-
Capowski, E. E., Esnault, S., Bhattacharya, S., Malter, J. S.
(2001). Y Box-Binding Factor Promotes Eosinophil Survival by Stabilizing Granulocyte-Macrophage Colony-Stimulating Factor mRNA. J. Immunol.
167: 5970-5976
[Abstract]
[Full Text]
-
McNeil, G. P., Schroeder, A. J., Roberts, M. A., Jackson, F. R.
(2001). Genetic Analysis of Functional Domains Within the Drosophila LARK RNA-Binding Protein. Genetics
159: 229-240
[Abstract]
[Full Text]
-
Katsamba, P. S., Myszka, D. G., Laird-Offringa, I. A.
(2001). Two Functionally Distinct Steps Mediate High Affinity Binding of U1A Protein to U1 Hairpin II RNA. J. Biol. Chem.
276: 21476-21481
[Abstract]
[Full Text]